Navigation Links
FDA Advisers Weigh Approval of Genetically Modified Salmon
Date:9/20/2010

work geared toward regulatory approval to show that the fish is healthy and safe," Buchanan said.

Genetically modified animals have been produced since the 1970s, according to background information in the FDA's briefing materials, but none have been approved for human consumption.

AquaBounty said bringing the salmon to market would take at least 18 months after approval. Farmers who want to grow the fish would also need FDA approval of their facilities.

One question for consumers is whether packaging would be required to specify that the salmon is genetically modified. The FDA will consider that issue during the public hearings.

More information

Read what the U.S. Food and Drug Administration advisory panel had to say about genetically modified salmon.

SOURCES: Wenonah Hauter, executive director, Food & Water Watch, Washington. D.C.; John Buchanan, Ph.D., director, research and development, AquaBounty Technologies, San Diego


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Advisers Urge Stricter Regulation of Tanning Beds
2. FDA to Broaden Disclosure on Advisers Conflicts of Interest
3. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
4. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
5. Maximized Living Named as Exclusive Chiropractic Partner of USA Weightlifting
6. New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle
7. New York and Connecticut Drug Rehab Center Mountainside Weighs In on Latest White House Budget
8. Repeated Weight-Loss Surgery Carries Added Risks
9. Fitness Trend Towards Online Personal Training Gets Real-World Weight Loss Results on FitOrbit.com
10. Enovate Announces New Lightweight Medication Cart Series
11. New Weight Loss Aid?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Advisers Weigh Approval of Genetically Modified Salmon
(Date:7/31/2014)... the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and ... will expedite the delivery of laboratory samples and ... districts of the Northern and Central Zones of ... for Health will establish a dependable and coordinated ... critical bottleneck in health services for the more ...
(Date:7/31/2014)... View, Calif. and Las Vegas, Nevada (PRWEB) July 31, ... partnership with LaunchKey to provide next generation authentication services ... simple and secure way to utilize hardware protected multi-factor ... enormous problem in the Internet's reliance on password-based authentication. ... hacks and global data breaches taking place around the ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... to reach USD 37.83 billion by 2020, according ... Inc. Increasing geriatric population base augmenting the susceptibility ... orthopedic, and respiratory diseases coupled with increasing patient ... over the next six years. Some of the ...
(Date:7/31/2014)... 31, 2014 (HealthDay News) -- Recovery time after surgery ... known as statins, according to a new study. ... affect the body,s inflammatory response, reducing the amount of ... seemed to be particularly true among people who tend ... of the most widely prescribed medications in the world. ...
(Date:7/31/2014)... 2014 A new catheter being ... helping patients who have an abnormal heart rhythm. ... ablation procedures for patients such as those suffering ... Baptist Heart Specialists were the first in north ... past spring, according to Biosense Webster, which develops ...
Breaking Medicine News(10 mins):Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Cholesterol Drugs May Speed Healing After Surgery 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3
... near the World Trade Center had sleeplessness, other problems, ... Direct exposure to the World Trade Center terrorist ... , The study, by researchers at the Mount Sinai ... children averaging about 4 years of age who lived ...
... Merrill Lynch,s Global Pharmaceutical Conference Feb. ... 5, 2008, ... it will host a conference call and live webcast on,Wednesday, Feb. 27, 2008, ... ended Dec. 31, 2007. The Company also will provide,an operational and integration update ...
... CLARA, Calif., Feb. 5 Coherent, Inc.,(Pink Sheets: COHR), ... included in the company,s proxy for the annual meeting ... subject to election by,shareholders. The nominees include current directors ... Vij as well as first-time,nominees Susan James and Clifford ...
... Engineering,Group Inc. (NYSE: JEC ) announced today that ... in managing the Sequoia Hospital Program,in Redwood City, Calif. ... including a new 104-bed tower, a retrofit of 63 ... a parking structure. The,overall project is expected to be ...
... VIEW, Calif., Feb. 5 MAP,Pharmaceuticals, Inc. (Nasdaq: ... B. Shrewsbury, M.B., Ch.B., Chief Medical,Officer, will be leaving ... Shrewsbury plans to provide consulting services to the company,for ... want to thank Steve for his many contributions and ...
... Feb. 5 Favrille, Inc. (Nasdaq:,FVRL), a biopharmaceutical ... cancer, announced today that it will,host a conference ... Time on,Tuesday, February 19, 2008 to discuss the ... A press release will be issued before the ...
Cached Medicine News:Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2Health News:Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007 2Health News:Coherent Announces Director Slate for Upcoming Annual Meeting 2Health News:Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program 2Health News:MAP Pharmaceuticals Announces Resignation of Chief Medical Officer 2Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
(Date:7/31/2014)... , July 31, 2014 Astellas ... head of corporate and employee communications in the ... Jeff Winton , senior vice president, chief communications ... for developing and leading corporate brand initiatives and ... across North and South America ...
(Date:7/31/2014)... -- Cryoport, Inc. (OTCBB: CYRX) today announced financial results ... Recent Operating Highlights , Achieved ... month period ended June 30, 2014 compared to the ... further expand Cryoport,s global reach using the ,powered by ... Immudex, an immunotherapy and vaccine development services company, to ...
(Date:7/31/2014)... 2014 Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" ... premium branded consumer products, including commercially cultivated Cordyceps Militaris ... announced the signing of its first distributor for its ... Hubei Province located ... . The contract with the ...
Breaking Medicine Technology:Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
PremierEdge Stab Knives - 30....
... for the total eye. Whether used ... mode or set independently to accommodate ... settings are adjustable to accommodate maximizing ... for use with tonometer-mounted, hand-held and ...
PremierEdge™ MVR Knives. Angled....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: